Ausgenex’s state-of-the-art production facilities ensure the highest quality of our serum products, supporting the success of your research. Our commitment to quality and consistency in serum production is crucial for research success in cell culture, vaccine production, and monoclonal antibody development.
Ausgenex’s production facilities operate under strict current Good Manufacturing Practice (cGMP) guidelines and are registered with [XXXX]. From raw serum collection to the final sterile-filtered product, we meticulously control and document every process, ensuring complete traceability from the animal to the final product that ships to you. Full batch records, including Certificates of Suitability, Certificates of Analysis, and other batch release documents, are available to all customers.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Advanced technology ensures rigorous quality control, keeping serum products free from contaminants like viruses, bacteria, and endotoxins—vital for research and clinical applications.
Modern facilities provide consistent batch-to-batch quality, essential for reproducible research results.
With the latest sterilization and filtration methods, serum products meet strict sterility requirements, ensuring safety in sensitive experiments such as viral research or cell culture.
Our facilities enable the creation of tailored serum products, including those with reduced immunoglobulin G (IgG) or specially tested sera for specific research needs (e.g., hybridomas, stem cells).
Ausgenex’s animal serum collection and processing adhere to stringent standards to ensure high-quality products for research and manufacturing applications.
All raw sera are processed in Ausgenex’s state-of-the-art, cGMP-compliant, FDA-registered production facilities. The processing steps include:
Each batch undergoes extensive testing by the Quality Control (QC) department. Detailed specifications and test results are available on the corresponding Certificate of Analysis (CoA). For FBS products, which must comply with higher safety standards, additional animal virus testing is conducted in line with 9CFR and EP3 regulations. The “Pharma Grade” FBS from Ausgenex meets these stringent regulations, with sera of both USA and Australian origin available. This grade is particularly suitable for industrial production and advanced cell therapy research.
All FBS products are packaged in gamma-irradiated 100 and 500 ml PET bottles. Alternative containers and volumes are available upon request.